It has been reported that this is one of the most common pharmaceutical products to cause DILI.15 Mortality rates have been approximated at 0.4% in overdose patients, translating to 300 deaths annually in the United States.1 Although toxic ingestions causing hepatic failure are usually in excess of 150 mg/kg, an increasing number of reports has arisen to suggest that lower doses of APAP may confer acute liver injury and liver failure.14 A so-called therapeutic misadventure phenomenon, as coined by Zimmerman et al ., is becoming increasingly acknowledged, as some patients have presented with acute liver failure despite consumption of safe doses of APAP
10.1073/pnas.0808723105 Proc Natl Acad Sci U S A
From the active site, structural changes induced by ATP hydrolysis must be relayed towards the NTD, where they ultimately induce a downward motion
The immune system connects the gut microbiota with systemic energy homeostasis: focus on TLRs, mucosal barrier, and SCFAs
CD4 + Th17 cells are the primary source of IL-17 in psoriatic lesions, and IL-17A the core subtype of this cytokine drives the inflammatory response in keratinocytes
Srinivas P
